Literature DB >> 31859080

The Mexican consensus on the detection and treatment of early gastric cancer.

M E Icaza-Chávez1, M A Tanimoto2, F M Huerta-Iga3, J M Remes-Troche4, R Carmona-Sánchez5, A Ángeles-Ángeles6, F J Bosques-Padilla7, J M Blancas-Valencia8, G Grajales-Figueroa9, O V Hernández-Mondragón10, A I Hernández-Guerrero11, M A Herrera-Servín11, F D Huitzil-Meléndez12, K Kimura-Fujikami13, E León-Rodríguez12, H Medina-Franco14, M A Ramírez-Luna9, C L Sampieri15, B Vega-Ramos16, A Zentella-Dehesa17.   

Abstract

Gastric cancer is one of the most frequent neoplasias in the digestive tract and is the result of premalignant lesion progression in the majority of cases. Opportune detection of those lesions is relevant, given that timely treatment offers the possibility of cure. There is no consensus in Mexico on the early detection of gastric cancer, and therefore, the Asociación Mexicana de Gastroenterología brought together a group of experts and produced the "Mexican consensus on the detection and treatment of early gastric cancer" to establish useful recommendations for the medical community. The Delphi methodology was employed, and 38 recommendations related to early gastric cancer were formulated. The consensus defines early gastric cancer as that which at diagnosis is limited to the mucosa and submucosa, irrespective of lymph node metástasis. In Mexico, as in other parts of the world, factors associated with early gastric cancer include Helicobacter pylori infection, a family history of the disease, smoking, and diet. Chromoendoscopy, magnification endoscopy, and equipment-based image-enhanced endoscopy are recommended for making the diagnosis, and accurate histopathologic diagnosis is invaluable for making therapeutic decisions. The endoscopic treatment of early gastric cancer, whether dissection or resection of the mucosa, should be preferred to surgical management, when similar oncologic cure results can be obtained. Endoscopic surveillance should be individualized.
Copyright © 2019 Asociación Mexicana de Gastroenterología. Publicado por Masson Doyma México S.A. All rights reserved.

Entities:  

Keywords:  Cáncer gástrico; Displasia; Dysplasia; Early-stage; Gastric cancer; Helicobacter pylori; Incipiente; Metaplasia; Mexico; México

Mesh:

Year:  2019        PMID: 31859080     DOI: 10.1016/j.rgmx.2019.10.001

Source DB:  PubMed          Journal:  Rev Gastroenterol Mex (Engl Ed)        ISSN: 2255-534X


  3 in total

1.  Segmentation of Gastric Computerized Tomography Images under Intelligent Algorithms in Evaluation of Efficacy of Decitabine Combined with Paclitaxel in Treatment of Gastric Cancer.

Authors:  Zhenghui Ge; Mengyun Wang; Qun Liu
Journal:  J Healthc Eng       Date:  2021-10-27       Impact factor: 2.682

Review 2.  Proposal of minimum elements for screening and diagnosis of gastric cancer by an international Delphi consensus.

Authors:  Naomi Kakushima; Mitsuhiro Fujishiro; Shannon Melissa Chan; George Adel Cortas; Mario Dinis-Ribeiro; Robinson Gonzalez; Shinya Kodashima; Sun-Young Lee; Enqiang Linghu; Katsuhiro Mabe; Wensheng Pan; Adolfo Parra-Blanco; Mathieu Pioche; Antonio Rollan; Kazuki Sumiyama; Miguel Tanimoto
Journal:  DEN open       Date:  2022-02-24

3.  Abdominal Computed Tomography Enhanced Image Features under an Automatic Segmentation Algorithm in Identification of Gastric Cancer and Gastric Lymphoma.

Authors:  Lihua Zhou; Hao Hu; Lei Zhou; Yi Zhou
Journal:  Comput Math Methods Med       Date:  2022-07-26       Impact factor: 2.809

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.